Sun Pharma shares rose sharply on Sunday after the company reported a 16% YoY rise in Q3 net profit to Rs 3,369 crore, supported by strong India business and improved margins. The firm also declared an interim dividend of Rs 11 per share, further boosting sentiment despite cautious institutional activity.
RBI maintains optimism on growth, signals caution on inflation and FX volatility: Anubhuti Sahay
The Reserve Bank of India’s latest policy stance balances optimism on growth with caution on inflation and foreign exchange volatility. Analysts noted the central bank’s